Skip to main content
. 2014 Feb 14;5:15. doi: 10.3389/fpsyt.2014.00015

Figure 8.

Figure 8

Ethosuximide attenuated the cognitive control impairment of NVHL rats. (A) In the untreated group, the NVHL rats were slower to learn the two-frame task and showed an impairment when compared to the control rats (learning curve: two-way repeated-measures ANOVA group: F1,64 = 53.84, p < 0.0001; trial: F7,64 = 8.80, p < 0.0001; interaction: F7,64 = 1.79, p = 0.10); inset: total number of entrances: t8 = 4.69, p = 0.002). (B) Ethosuximide treatment attenuated the learning impairment in the NVHL rats when compared to control rats (learning curve: two-way repeated-measures ANOVA group: F1,64 = 5.86, p = 0.02; trial: F7,64 = 9.79, p < 0.0001; interaction: F7,64 = 2.40, p = 0.03); inset: total number of entrances: t8 = 1.87, p = 0.10). (C) Olanzapine treatment did not improve performance of the NVHL rats on the two-frame task (learning curve: two-way repeated-measures ANOVA group: F1,64 = 42.87, p < 0.0001; trial: F7,64 = 9.66, p < 0.0001; interaction: F7,64 = 0.19, p = 0.99); inset: total number of entrances: t8 = 3.10, p = 0.02).